CA 23318/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1980	7
1981	13
1982	16
1983	8
1984	15
1985	23
1986	12
1987	16
1988	4
1989	6
1990	12
1991	6
1992	15
1993	12
1994	8
1995	3
1996	7
1997	6
1998	8
1999	6
2000	3
2001	3
2002	3
2003	5
2004	5
2005	2
2006	1
2007	2
2008	1
2009	1
2010	1
2011	2
2012	1
2013	1
2015	1
2016	1
2021	0

1

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.

Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH; Eastern Cooperative Oncology Group. Schiller JH, et al. N Engl J Med. 2002 Jan 10;346(2):92-8. doi: 10.1056/NEJMoa011954. N Engl J Med. 2002. PMID: 11784875 Free article. Clinical Trial.

2

Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma.

Lemma GL, Lee JW, Aisner SC, Langer CJ, Tester WJ, Johnson DH, Loehrer PJ Sr. Lemma GL, et al. J Clin Oncol. 2011 May 20;29(15):2060-5. doi: 10.1200/JCO.2010.32.9607. Epub 2011 Apr 18. J Clin Oncol. 2011. PMID: 21502559 Free PMC article. Clinical Trial.

3

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO Jr, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC. Dewys WD, et al. Am J Med. 1980 Oct;69(4):491-7. doi: 10.1016/s0149-2918(05)80001-3. Am J Med. 1980. PMID: 7424938

4

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

Edmonson JH, Ryan LM, Blum RH, Brooks JS, Shiraki M, Frytak S, Parkinson DR. Edmonson JH, et al. J Clin Oncol. 1993 Jul;11(7):1269-75. doi: 10.1200/JCO.1993.11.7.1269. J Clin Oncol. 1993. PMID: 8315424 Clinical Trial.

5

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Kirkwood JM, et al. J Clin Oncol. 1996 Jan;14(1):7-17. doi: 10.1200/JCO.1996.14.1.7. J Clin Oncol. 1996. PMID: 8558223 Clinical Trial.

6

Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193).

Sledge GW, Neuberg D, Bernardo P, Ingle JN, Martino S, Rowinsky EK, Wood WC. Sledge GW, et al. J Clin Oncol. 2003 Feb 15;21(4):588-92. doi: 10.1200/JCO.2003.08.013. J Clin Oncol. 2003. PMID: 12586793 Clinical Trial.

7

Thymoma: current medical and surgical management.

Kesler KA, Wright CD, Loehrer PJ Sr. Kesler KA, et al. Semin Neurol. 2004 Mar;24(1):63-73. doi: 10.1055/s-2004-829588. Semin Neurol. 2004. PMID: 15229793 Review.

8

Thymoma and thymic carcinoma: therapeutic approaches.

Kurup A, Loehrer PJ Sr. Kurup A, et al. Clin Lung Cancer. 2004 Jul;6(1):28-32. doi: 10.3816/CLC.2004.n.018. Clin Lung Cancer. 2004. PMID: 15310414 Review.

9

Current approaches to the treatment of thymoma.

Loehrer PJ Sr. Loehrer PJ Sr. Ann Med. 1999 Oct;31 Suppl 2:73-9. Ann Med. 1999. PMID: 10574160 Review.

10

Duration of high-dose interferon alpha-2b regimen for resected high-risk melanoma.

Agarwala SS, Gray RJ, Wong MK. Agarwala SS, et al. J Clin Oncol. 2009 Sep 1;27(25):e82-3; author reply e84. doi: 10.1200/JCO.2009.23.0334. Epub 2009 Jul 27. J Clin Oncol. 2009. PMID: 19635995 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results